Legal and professional costs overhang
Elevated legal costs of INR 6-7 crore in Q2 due to ongoing litigation; timing of resolution is uncertain and could continue to pressure margins.
medium · management_commentary
Fortis Healthcare Limited — Q2 FY24
Fortis Healthcare reported a strong Q2 FY24 with consolidated revenue of INR 1,770 crore (+10.1% YoY) and operating EBITDA of INR 330 crore (+8.9% YoY).
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Doctor cost inflation and talent churn
Analyst raised concern about rising guaranteed payouts for clinicians; management acknowledged some churn but deemed risk low. However, cost pressures could impact margin trajectory.
medium · analyst_questionDelays in bed commissioning
Management identified potential delays in brownfield bed commissioning as a key risk to achieving FY25 margin targets.
medium · management_commentaryLow-margin oncology mix drags margins
Rapid growth in medical oncology (lower margin) relative to surgical oncology could cap margin expansion despite absolute EBITDA growth.
low · data_observation